Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lymphoma × Drug Therapy × Clear all

Phase

Status

Completed 9 Unknown 3 Withdrawn 2 Recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 10 Carcinoma, Non-Small-Cell Lung 10 Breast Neoplasms 6 Prostatic Neoplasms 4 Lung Neoplasms 4 Leukemia, Myeloid, Acute 4 Neoplasms 3 Colorectal Neoplasms 3 Cholangiocarcinoma 3 Triple Negative Breast Neoplasms 2 Sarcoma 2 Recurrence 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Melanoma 2 Leukemia 2 Gliosarcoma 2 Glioblastoma 2 Congenital Abnormalities 2 Colonic Neoplasms 2 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Thrombocythemia, Essential 1 Squamous Cell Carcinoma of Head and Neck 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pleural Effusion, Malignant 1 Pain 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1

Interventions

Rituximab 54 Cyclophosphamide 46 fludarabine phosphate 21 fludarabine 20 Filgrastim 19 Methotrexate 17 Vincristine 16 Radiotherapy 16 Melphalan 16 Etoposide 16 Doxorubicin 15 Cytarabine 13 Whole-Body Irradiation 12 Tacrolimus 12 Prednisone 12 Mycophenolic Acid 12 Gemcitabine 12 Cyclosporine 12 Antilymphocyte Serum 12 Peripheral Blood Stem Cell Transplantation 11 Lenalidomide 11 Busulfan 9 Granulocyte Colony-Stimulating Factor 8 Dexamethasone 8 Cord Blood Stem Cell Transplantation 8 sargramostim 7 Vorinostat 7 Methylprednisolone 7 Bortezomib 7 Alemtuzumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01016795 2015-06-25

SCF980266

Aalborg University Hospital

Phase 2 Terminated

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡